Rodin Therapeutics' Series B - II Round

Rodin Therapeutics raised a round of funding on September 14, 2017.

Rodin Therapeutics is discovering and developing first in class therapeutics for cognitive disorders, applying unique insights into the role of epigenetics and best in class structural biology capabil…

Articles about Rodin Therapeutics' Series B - II Round: